Skip to content

Feed Screener MCP Methodology

⌘K

EN

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
AMF · FR
BAFIN · DE

Product

Ask the record
Help
Methodology
Signal backtests
Terms
Privacy notice
Object to processing

Language

English Español Français

Feed Screener MCP Methodology

English Español Français

Pricing Sign in

Beeby Reshentha — Acer Therapeutics Inc. insider: 1 transactions · InsiderLens

/ / Beeby Reshentha

Beeby Reshentha

10% owner at Acer Therapeutics Inc. · on record since Aug 22, 2018

Insider trading activity of Beeby Reshentha

Transactions on record: 1; since Aug 22, 2018

Open-market buys: 1; $5M

Open-market sells: 0

Companies traded: 1; last filing Aug 22, 2018

Figures computed from official regulatory filings — .

Companies where Beeby Reshentha has traded

Acer Therapeutics Inc.1 tx · $5M · Aug 22, 2018

Track record of Beeby Reshentha

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Beeby Reshentha

Co-insiders of Beeby Reshentha

Adduci JeffreyAcer Therapeutics Inc.
Albert & Margaret Alkek FoundationAcer Therapeutics Inc.
Amello JasonAcer Therapeutics Inc.
Andrews William T.Acer Therapeutics Inc.
ASELAGE STEVEAcer Therapeutics Inc.
Bailey GregoryAcer Therapeutics Inc.
BARABE TIMOTHY CAcer Therapeutics Inc.
Birner HubertAcer Therapeutics Inc.
BOVEROUX BROOKSAcer Therapeutics Inc.
BURRIS MICHELLEAcer Therapeutics Inc.
Davis Jefferson EAcer Therapeutics Inc.
DESLATTE DWAYNEAcer Therapeutics Inc.
DUNN JOHN MICHAELAcer Therapeutics Inc.
Fischer StefanAcer Therapeutics Inc.
Frison PaulAcer Therapeutics Inc.
FRITZSCHE R WAYNEAcer Therapeutics Inc.
Gow Robert HAcer Therapeutics Inc.
Hartung Hans-PeterAcer Therapeutics Inc.
Hayden TanyaAcer Therapeutics Inc.
Healey DonAcer Therapeutics Inc.
Hohlfeld LynneAcer Therapeutics Inc.
Hung DavidAcer Therapeutics Inc.
JARKESY GEORGEAcer Therapeutics Inc.
JORDEN DAVID EMERSONAcer Therapeutics Inc.
Joseph DonaldAcer Therapeutics Inc.
Jutt-Eghbali SalmaAcer Therapeutics Inc.
Kamin TonyAcer Therapeutics Inc.
Klopp John MichaelAcer Therapeutics Inc.
Lau Warren CAcer Therapeutics Inc.
Leatt GaryAcer Therapeutics Inc.
Litowitz Alec NAcer Therapeutics Inc.
Maderis Gail JAcer Therapeutics Inc.

This page republishes public regulatory disclosures.

Magnetar Capital Partners LPAcer Therapeutics Inc.

Magnetar Financial LLCAcer Therapeutics Inc.

Marengere LucAcer Therapeutics Inc.

MARXE AUSTIN W & GREENHOUSE DAVID MAcer Therapeutics Inc.

McWilliams DavidAcer Therapeutics Inc.

OTTESON JASON GAcer Therapeutics Inc.

PALMIN HARRY SAcer Therapeutics Inc.

Paul Bernard HAcer Therapeutics Inc.

Quartel Adrian WAcer Therapeutics Inc.

Radhakrishnan KarthikAcer Therapeutics Inc.

Randall LorinAcer Therapeutics Inc.

Richman MichaelAcer Therapeutics Inc.

Rill Donna RAcer Therapeutics Inc.

Rodriguez BrianAcer Therapeutics Inc.

ROTH MICHAELAcer Therapeutics Inc.

Rouse WilliamAcer Therapeutics Inc.

Schelling ChrisAcer Therapeutics Inc.

SCHUHSLER HELMUTAcer Therapeutics Inc.

Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src	Details
Acer Therapeutics Inc.Listing unverified	Aug 22, 2018	Buy	275,000	18.00 USD	$5M	conv 32First in 12mo	SEC